基于小基因的剪接分析与ACMG/AMP对56个ATM变异初步分类
该研究针对大规模测序项目BRIDGES中发现的381个内含子-外显子边界变异,筛选出56个 predicted spliceogenic 的ATM变异,利用四个小基因(mgATM)在MCF-7/HeLa细胞中进行剪接分析。基于ACMG/AMP的初步分类方案将29个变异归类为致病/可能致病,7个为可能良性。
要点
- 小基因剪接分析可有效识别ATM剪接致病变异。
- 85.7%的所选变异损害剪接,多数导致外显子跳跃。
- 整合mgATM数据的ACMG/AMP分类有助于变异解读。
核心结论
- 小基因剪接分析结合ACMG/AMP分类方案可对ATM剪接变异进行初步分类。
- 多数预测剪接致病的ATM变异经mgATM分析确认损害剪接。
研究设计与样本
- 研究基于BRIDGES项目,识别381个内含子-外显子边界变异,筛选56个进行剪接分析。
- 构建四个小基因(mgATM)覆盖外显子4-9、11-17、25-29和49-52,在MCF-7/HeLa细胞中 assay。
主要发现
- 基于ACMG/AMP的初步分类方案将29个ATM变异归类为致病/可能致病,7个为可能良性。
- 可能致病性变异c.1898+2T>G因使用非经典GG-5'剪接位点产生13%的小基因全长转录本。
关键数值与推荐
- 32个变异无全长转录本。
- 29个变异分类为致病/可能致病,7个为可能良性。
- c.1898+2T>G产生13%全长转录本。
临床怎么用
- 对于疑似ATM剪接变异,可考虑小基因剪接分析辅助解读。
- 整合功能数据与ACMG/AMP分类可提高变异分类准确性。
局限性
- 研究为初步分类,需进一步验证。
- 小基因分析仅覆盖部分外显子区域。
- 剂量敏感表达模型基于间接证据,需更多数据支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The ataxia telangiectasia-mutated (ATM) protein is a major coordinator of the DNA damage response pathway. ATM loss-of-function variants are associated with 2-fold increased breast cancer risk. We aimed at identifying and classifying spliceogenic ATM variants detected in subjects of the large-scale sequencing project BRIDGES. A total of 381 variants at the intron-exon boundaries were identified, 128 of which were predicted to be spliceogenic. After further filtering, we ended up selecting 56 variants for splicing analysis. Four functional minigenes (mgATM) spanning exons 4-9, 11-17, 25-29, and 49-52 were constructed in the splicing plasmid pSAD. Selected variants were genetically engineered into the four constructs and assayed in MCF-7/HeLa cells. Forty-eight variants (85.7%) impaired splicing, 32 of which did not show any trace of the full-length (FL) transcript. A total of 43 transcripts were identified where the most prevalent event was exon/multi-exon skipping. Twenty-seven transcripts were predicted to truncate the ATM protein. A tentative ACMG/AMP (American College of Medical Genetics and Genomics/Association for Molecular Pathology)-based classification scheme that integrates mgATM data allowed us to classify 29 ATM variants as pathogenic/likely pathogenic and seven variants as likely benign. Interestingly, the likely pathogenic variant c.1898+2T>G generated 13% of the minigene FL-transcript due to the use of a noncanonical GG-5'-splice-site (0.014% of human donor sites). Circumstantial evidence in three ATM variants (leakiness uncovered by our mgATM analysis together with clinical data) provides some support for a dosage-sensitive expression model in which variants producing ≥30% of FL-transcripts would be predicted benign, while variants producing ≤13% of FL-transcripts might be pathogenic. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
引用
- Bueno-Martínez E, Sanoguera-Miralles L, Valenzuela-Palomo A, et al. Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants. J Pathol. 2022. PMID: 35716007. doi:10.1002/path.5979
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。